Correlating liver stiffness with disease severity scoring system (DS3) values in Gaucher disease type 1 (GD1) patients

2018 ◽  
Vol 123 (3) ◽  
pp. 357-363 ◽  
Author(s):  
Suraj D. Serai ◽  
Anjani P. Naidu ◽  
T. Andrew Burrow ◽  
Carlos E. Prada ◽  
Stavra Xanthakos ◽  
...  
Keyword(s):  
Disease Severity ◽  
Scoring System ◽  
Gaucher Disease ◽  
Liver Stiffness ◽  
Disease Type ◽  
Severity Scoring ◽  
Gaucher Disease Type 1

148. A validated disease severity scoring system for gaucher disease type 1

2009 ◽  
Vol 96 (2) ◽  
pp. S45
Author(s):  
Neal Weinreb ◽  
Maria Cappellini ◽  
Timothy Cox ◽  
Edward Giannini ◽  
Gregory Grabowski ◽  
...  
Keyword(s):  
Disease Severity ◽  
Scoring System ◽  
Gaucher Disease ◽  
Disease Type ◽  
Severity Scoring ◽  
Gaucher Disease Type 1

scholarly journals A validated disease severity scoring system for adults with type 1 Gaucher disease

2009 ◽  
Vol 12 (1) ◽  
pp. 44-51 ◽  
Author(s):  
Neal J Weinreb ◽  
Maria D Cappellini ◽  
Timothy M Cox ◽  
Edward H Giannini ◽  
Gregory A Grabowski ◽  
...  
Keyword(s):  
Disease Severity ◽  
Scoring System ◽  
Gaucher Disease ◽  
Severity Scoring ◽  
Type 1 Gaucher Disease

Transition to eliglustat in an individual with Gaucher disease type 1 on antipsychotic medication

2021 ◽  
Vol 132 (2) ◽  
pp. S80
Author(s):  
Damara Ortiz ◽  
Joshua Barch ◽  
Kayla Segady ◽  
Nadene Henderson
Keyword(s):  
Antipsychotic Medication ◽  
Gaucher Disease ◽  
Disease Type ◽  
Gaucher Disease Type 1

scholarly journals Cardiac Manifestations in a Group of Romanian Patients with Gaucher Disease Type 1 (a Monocentric Study)

Diagnostics ◽  
2021 ◽  
Vol 11 (6) ◽  
pp. 989
Author(s):  
Cecilia Lazea ◽  
Simona Bucerzan ◽  
Camelia Al-Khzouz ◽  
Anca Zimmermann ◽  
Ștefan Cristian Vesa ◽  
...  
Keyword(s):  
Gaucher Disease ◽  
Cardiac Involvement ◽  
Disease Type ◽  
Clinical Onset ◽  
Lysosomal Disorders ◽  
Electrocardiographic Changes ◽  
Gaucher Disease Type 1 ◽  
And Function ◽  
Cardiac Manifestations

Gaucher disease (GD), one of the most common lysosomal disorders, is characterised by clinical heterogeneity. Cardiac involvement is rare and refers to pulmonary hypertension (PH), valvular abnormalities and myocardial infiltrative damage. The aim of this study was to evaluate cardiac involvement in a group of Romanian GD patients. Phenotypic and genotypic characterisation was carried out in 69 patients with GD type 1. Annual echocardiography and electrocardiography were performed to assess pulmonary pressure, morphology and function of the valves and electrocardiographic changes. Nine patients (13%) exhibited baseline echocardiographic signs suggesting PH. Mitral regurgitation was present in 33 patients (48%) and aortic regurgitation in 11 patients (16%). One patient presented aortic stenosis. Significant valvular dysfunction was diagnosed in 10% of patients. PH was associated with greater age (p < 0.001), longer time since splenectomy (p = 0.045) and longer time between clinical onset and the start of enzyme replacing therapy (p < 0.001). Electrocardiographic changes were present in five patients (7%).

Addendum to Letter to the Editor: Safety, efficacy, and authorization of eliglustat as a first-line therapy in Gaucher disease type 1

2019 ◽  
Vol 77 ◽  
pp. 101-102 ◽  
Author(s):  
Pramod K. Mistry ◽  
Manisha Balwani ◽  
Hagit N. Baris ◽  
Hadhami Ben Turkia ◽  
T. Andrew Burrow ◽  
...  
Keyword(s):  
Gaucher Disease ◽  
Disease Type ◽  
First Line ◽  
First Line Therapy ◽  
Line Therapy ◽  
Letter To The Editor ◽  
Gaucher Disease Type 1
Sign in / Sign up

Export Citation Format

Share Document